Neogen (NEOG) Stock Forecast, Price Target & Predictions
NEOG Stock Forecast
Neogen stock forecast is as follows: an average price target of $17.50 (represents a 8.49% upside from NEOG’s last price of $16.13) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
NEOG Price Target
The average price target for Neogen (NEOG) is $17.50 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $17.50 to $17.50. This represents a potential 8.49% upside from NEOG's last price of $16.13.
NEOG Analyst Ratings
According to 2 Wall Street analysts, Neogen's rating consensus is 'Buy'. The analyst rating breakdown for NEOG stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 1 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Neogen Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 06, 2024 | David Westenberg | Piper Sandler | $17.50 | $16.15 | 8.36% | 8.49% |
| Dec 14, 2022 | David Westenberg | Piper Sandler | $17.00 | $15.35 | 10.75% | 5.39% |
| Oct 09, 2022 | David Westenberg | Piper Sandler | $14.00 | $12.68 | 10.41% | -13.21% |
The latest Neogen stock forecast, released on Aug 06, 2024 by David Westenberg from Piper Sandler, set a price target of $17.50, which represents a 8.36% increase from the stock price at the time of the forecast ($16.15), and a 8.49% increase from NEOG last price ($16.13).
Neogen Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 1 |
| Avg Price Target | - | $17.50 | $17.50 |
| Last Closing Price | $16.13 | $16.13 | $16.13 |
| Upside/Downside | -100.00% | 8.49% | 8.49% |
In the current month, the average price target of Neogen stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Neogen's last price of $16.13. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 06, 2024 | Piper Sandler | Neutral | Neutral | Hold |
| Oct 10, 2023 | William Blair | Outperform | Outperform | Hold |
| Dec 14, 2022 | Piper Sandler | Neutral | Neutral | Hold |
| Nov 22, 2022 | William Blair | - | Outperform | Upgrade |
| Oct 09, 2022 | Piper Sandler | Neutral | Neutral | Hold |
Neogen's last stock rating was published by Piper Sandler on Aug 06, 2024. The company gave NEOG a "Neutral" rating, the same as its previous rate.
Neogen Financial Forecast
Neogen Revenue Forecast
| May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Nov 21 | Aug 21 | May 21 | Mar 21 | Nov 20 | Aug 20 | May 20 | Feb 20 | Nov 19 | Aug 19 | May 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | $228.99M | $241.81M | - | - | $132.35M | $140.09M | - | $130.52M | $128.31M | $127.42M | - | $115.00M | $109.33M | $109.07M | $99.87M | $107.80M | $101.42M | $109.76M | - |
| Avg Forecast | $263.15M | $248.30M | $239.70M | $227.90M | $255.66M | $237.49M | $226.66M | $215.05M | $225.83M | $229.61M | $232.85M | $231.10M | $227.72M | $218.87M | $228.30M | $131.73M | $135.74M | $130.00M | $129.06M | $121.20M | $122.32M | $106.73M | $115.16M | $105.79M | $112.15M | $102.42M | $110.17M | $105.16M | $110.14M | $102.55M |
| High Forecast | $263.15M | $248.30M | $239.70M | $227.90M | $255.66M | $237.49M | $226.66M | $215.26M | $225.83M | $229.61M | $236.20M | $231.10M | $227.72M | $218.87M | $228.30M | $158.07M | $162.89M | $133.08M | $132.12M | $124.07M | $125.22M | $109.26M | $117.89M | $108.30M | $114.81M | $104.84M | $112.79M | $107.65M | $112.75M | $104.98M |
| Low Forecast | $263.15M | $248.30M | $239.70M | $227.90M | $255.66M | $237.49M | $226.66M | $214.74M | $225.83M | $229.61M | $229.75M | $231.10M | $227.72M | $218.87M | $228.30M | $105.38M | $108.59M | $126.95M | $126.03M | $118.36M | $119.45M | $104.23M | $112.46M | $103.31M | $109.52M | $100.02M | $107.59M | $102.70M | $107.56M | $100.15M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | - | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 10 | 9 | 20 | 14 | - | 2 | 2 | 8 | 5 | 5 | 10 | 7 | 5 | 4 | 8 | 5 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 1.06% | - | - | 1.00% | 1.03% | - | 1.01% | 1.06% | 1.04% | - | 1.00% | 1.03% | 0.97% | 0.98% | 0.98% | 0.96% | 1.00% | - |
Neogen's average Quarter revenue forecast for Dec 23 based on 3 analysts is $232.85M, with a low forecast of $229.75M, and a high forecast of $236.20M. NEOG's average Quarter revenue forecast represents a 1.69% increase compared to the company's last Quarter revenue of $228.99M (Aug 23).
Neogen EBITDA Forecast
| May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Nov 21 | Aug 21 | May 21 | Mar 21 | Nov 20 | Aug 20 | May 20 | Feb 20 | Nov 19 | Aug 19 | May 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | - | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 10 | 9 | 20 | 14 | - | 2 | 2 | 8 | 5 | 5 | 10 | 7 | 5 | 4 | 8 | 5 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | $19.14M | $23.43M | - | - | $6.06M | $18.03M | - | $18.76M | $27.41M | $26.08M | - | $24.14M | $24.53M | $26.03M | $18.81M | $23.78M | $22.09M | $24.09M | - |
| Avg Forecast | $36.40M | $34.34M | $33.15M | $31.52M | $35.36M | $32.85M | $31.35M | $29.74M | $31.23M | $24.10M | $32.21M | $31.96M | $31.50M | $21.91M | $31.58M | $28.14M | $21.08M | $19.92M | $23.83M | $25.58M | $27.71M | $22.39M | $25.65M | $22.78M | $25.16M | $21.59M | $24.52M | $23.56M | $24.09M | $22.61M |
| High Forecast | $36.40M | $34.34M | $33.15M | $31.52M | $35.36M | $32.85M | $31.35M | $29.77M | $31.23M | $28.92M | $32.67M | $31.96M | $31.50M | $26.29M | $31.58M | $33.77M | $25.30M | $23.90M | $28.60M | $30.70M | $33.25M | $26.87M | $30.78M | $27.33M | $30.20M | $25.91M | $29.42M | $28.27M | $28.91M | $27.14M |
| Low Forecast | $36.40M | $34.34M | $33.15M | $31.52M | $35.36M | $32.85M | $31.35M | $29.70M | $31.23M | $19.28M | $31.78M | $31.96M | $31.50M | $17.53M | $31.58M | $22.51M | $16.86M | $15.93M | $19.07M | $20.47M | $22.17M | $17.91M | $20.52M | $18.22M | $20.13M | $17.27M | $19.62M | $18.85M | $19.28M | $18.09M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.60% | 0.74% | - | - | 0.22% | 0.86% | - | 0.79% | 1.07% | 0.94% | - | 0.94% | 1.08% | 1.03% | 0.87% | 0.97% | 0.94% | 1.00% | - |
3 analysts predict NEOG's average Quarter EBITDA for Dec 23 to be $32.21M, with a high of $32.67M and a low of $31.78M. This is 68.31% upper than Neogen's previous annual EBITDA (Aug 23) of $19.14M.
Neogen Net Income Forecast
| May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Nov 21 | Aug 21 | May 21 | Mar 21 | Nov 20 | Aug 20 | May 20 | Feb 20 | Nov 19 | Aug 19 | May 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | - | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 10 | 9 | 20 | 14 | - | 2 | 2 | 8 | 5 | 5 | 10 | 7 | 5 | 4 | 8 | 5 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | $1.50M | $5.57M | - | - | $5.21M | $14.96M | - | $10.83M | $17.08M | $15.76M | - | $15.88M | $15.86M | $16.35M | $12.20M | $16.28M | $14.65M | $15.81M | - |
| Avg Forecast | $10.83M | $8.66M | $4.33M | $4.33M | $13.72M | $4.33M | $-2.17M | $-7.22M | $-2.17M | $9.88M | $5.42M | $5.42M | $2.89M | $8.98M | $-17.33M | $17.53M | $12.47M | $8.16M | $13.76M | $15.94M | $16.75M | $13.89M | $16.88M | $14.73M | $15.80M | $14.01M | $16.78M | $15.63M | $15.81M | $14.04M |
| High Forecast | $10.83M | $8.66M | $4.33M | $4.33M | $13.72M | $4.33M | $-2.17M | $-6.50M | $-2.17M | $11.85M | $5.42M | $5.42M | $2.89M | $10.78M | $-17.33M | $21.04M | $14.96M | $9.80M | $16.51M | $19.13M | $20.09M | $16.67M | $20.25M | $17.67M | $18.96M | $16.81M | $20.14M | $18.75M | $18.98M | $16.85M |
| Low Forecast | $10.83M | $8.66M | $4.33M | $4.33M | $13.72M | $4.33M | $-2.17M | $-7.22M | $-2.17M | $7.90M | $5.05M | $5.42M | $2.89M | $7.18M | $-17.33M | $14.03M | $9.97M | $6.53M | $11.01M | $12.75M | $13.40M | $11.11M | $13.50M | $11.78M | $12.64M | $11.21M | $13.43M | $12.50M | $12.65M | $11.23M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.28% | 1.93% | - | - | 0.30% | 1.20% | - | 0.79% | 1.07% | 0.94% | - | 0.94% | 1.08% | 1.03% | 0.87% | 0.97% | 0.94% | 1.00% | - |
Neogen's average Quarter net income forecast for Dec 23 is $5.42M, with a range of $5.05M to $5.42M. NEOG's average Quarter net income forecast represents a 260.30% increase compared to the company's last Quarter net income of $1.50M (Aug 23).
Neogen SG&A Forecast
| May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Nov 21 | Aug 21 | May 21 | Mar 21 | Nov 20 | Aug 20 | May 20 | Feb 20 | Nov 19 | Aug 19 | May 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | - | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 10 | 9 | 20 | 14 | - | 2 | 2 | 8 | 5 | 5 | 10 | 7 | 5 | 4 | 8 | 5 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | $90.90M | $92.70M | - | - | $51.33M | $43.14M | - | $43.79M | $33.94M | $33.36M | - | $29.91M | $27.53M | $28.33M | $28.46M | $28.97M | $28.24M | $28.23M | - |
| Avg Forecast | $87.63M | $82.68M | $79.82M | $75.89M | $85.13M | $79.08M | $75.47M | $71.61M | $75.20M | $84.35M | $77.54M | $76.95M | $75.83M | $76.68M | $76.02M | $34.84M | $35.95M | $69.71M | $55.64M | $31.68M | $35.44M | $35.14M | $31.78M | $25.56M | $27.38M | $32.68M | $29.88M | $30.12M | $28.23M | $28.72M |
| High Forecast | $87.63M | $82.68M | $79.82M | $75.89M | $85.13M | $79.08M | $75.47M | $71.68M | $75.20M | $101.22M | $78.65M | $76.95M | $75.83M | $92.02M | $76.02M | $41.81M | $43.14M | $83.65M | $66.77M | $38.01M | $42.53M | $42.17M | $38.14M | $30.68M | $32.86M | $39.22M | $35.85M | $36.15M | $33.88M | $34.46M |
| Low Forecast | $87.63M | $82.68M | $79.82M | $75.89M | $85.13M | $79.08M | $75.47M | $71.51M | $75.20M | $67.48M | $76.50M | $76.95M | $75.83M | $61.35M | $76.02M | $27.87M | $28.76M | $55.77M | $44.51M | $25.34M | $28.36M | $28.11M | $25.43M | $20.45M | $21.91M | $26.14M | $23.90M | $24.10M | $22.58M | $22.98M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 1.18% | 1.22% | - | - | 1.47% | 1.20% | - | 0.79% | 1.07% | 0.94% | - | 0.94% | 1.08% | 1.03% | 0.87% | 0.97% | 0.94% | 1.00% | - |
Neogen's average Quarter SG&A projection for Dec 23 is $77.54M, based on 3 Wall Street analysts, with a range of $76.50M to $78.65M. The forecast indicates a -14.71% fall compared to NEOG last annual SG&A of $90.90M (Aug 23).
Neogen EPS Forecast
| May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Nov 21 | Aug 21 | May 21 | Mar 21 | Nov 20 | Aug 20 | May 20 | Feb 20 | Nov 19 | Aug 19 | May 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | - | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 10 | 9 | 20 | 14 | - | 2 | 2 | 8 | 5 | 5 | 10 | 7 | 5 | 4 | 8 | 5 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.03 | - | - | $0.05 | $0.14 | - | $0.10 | $0.16 | $0.15 | - | $0.15 | $0.15 | $0.15 | $0.12 | $0.15 | $0.14 | $0.15 | - |
| Avg Forecast | $0.05 | $0.04 | $0.02 | $0.02 | $0.06 | $0.02 | $-0.01 | $-0.03 | $-0.01 | $0.01 | $0.03 | $0.03 | $0.01 | $-0.01 | $-0.08 | $1.27 | $1.15 | $0.12 | $0.17 | $0.16 | $0.14 | $0.13 | $0.16 | $0.14 | $0.15 | $0.14 | $0.16 | $0.15 | $0.15 | $0.14 |
| High Forecast | $0.05 | $0.04 | $0.02 | $0.02 | $0.06 | $0.02 | $-0.01 | $-0.03 | $-0.01 | $0.01 | $0.03 | $0.03 | $0.01 | $-0.01 | $-0.08 | $1.27 | $1.15 | $0.12 | $0.18 | $0.16 | $0.14 | $0.13 | $0.16 | $0.14 | $0.15 | $0.14 | $0.16 | $0.15 | $0.15 | $0.14 |
| Low Forecast | $0.05 | $0.04 | $0.02 | $0.02 | $0.06 | $0.02 | $-0.01 | $-0.03 | $-0.01 | $0.01 | $0.02 | $0.03 | $0.01 | $-0.01 | $-0.08 | $1.27 | $1.15 | $0.12 | $0.16 | $0.16 | $0.13 | $0.12 | $0.15 | $0.13 | $0.14 | $0.13 | $0.15 | $0.14 | $0.14 | $0.13 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.94% | - | - | 0.04% | 0.12% | - | 0.59% | 0.99% | 1.06% | - | 0.95% | 1.09% | 1.03% | 0.85% | 0.99% | 0.95% | 1.02% | - |
According to 1 Wall Street analysts, Neogen's projected average Quarter EPS for Aug 23 is $0.03, with a low estimate of $0.03 and a high estimate of $0.03. This represents a -3.10% decrease compared to NEOG previous annual EPS of $0.03 (May 23).
Neogen Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics | $1.18 | $25.00 | 2018.64% | Buy |
| GTH | Genetron | $4.03 | $10.00 | 148.14% | - |
| XGN | Exagen | $2.96 | $6.00 | 102.70% | Buy |
| MEDP | Medpace | $351.67 | $444.20 | 26.31% | Buy |
| QGEN | Qiagen | $46.36 | $52.37 | 12.96% | Buy |
| IQV | IQVIA | $238.70 | $269.43 | 12.87% | Buy |
| NEOG | Neogen | $16.13 | $17.50 | 8.49% | Buy |
| ICLR | ICON Public Limited Company | $300.00 | $307.63 | 2.54% | Buy |
| SHC | Sotera Health Company | $16.80 | $16.93 | 0.77% | Buy |
| MYGN | Myriad Genetics | $27.59 | $27.67 | 0.29% | Hold |
| RDNT | RadNet | $67.79 | $59.67 | -11.98% | Buy |
| OLK | Olink AB (publ) | $26.08 | $21.50 | -17.56% | Hold |
NEOG Forecast FAQ
Is Neogen a good buy?
Yes, according to 2 Wall Street analysts, Neogen (NEOG) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 50.00% of NEOG's total ratings.
What is NEOG's price target?
Neogen (NEOG) average price target is $17.5 with a range of $17.5 to $17.5, implying a 8.49% from its last price of $16.13. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Neogen stock go up soon?
According to Wall Street analysts' prediction for NEOG stock, the company can go up by 8.49% (from the last price of $16.13 to the average price target of $17.5), up by 8.49% based on the highest stock price target, and up by 8.49% based on the lowest stock price target.
Can Neogen stock reach $20?
NEOG's average twelve months analyst stock price target of $17.5 does not support the claim that Neogen can reach $20 in the near future.
What are Neogen's analysts' financial forecasts?
Neogen's analysts financial forecasts for the fiscal year (May 2025) are as follows: average revenue is $934.86M (high $935.07M, low $934.55M), average EBITDA is $129.3M (high $129.33M, low $129.26M), average net income is $8.66M (high $9.39M, low $8.66M), average SG&A $311.3M (high $311.37M, low $311.19M), and average EPS is $0.04 (high $0.0433, low $0.04). NEOG's analysts financial forecasts for the fiscal year (May 2026) are as follows: average revenue is $979.05M (high $979.05M, low $979.05M), average EBITDA is $135.41M (high $135.41M, low $135.41M), average net income is $28.16M (high $28.16M, low $28.16M), average SG&A $326.01M (high $326.01M, low $326.01M), and average EPS is $0.13 (high $0.13, low $0.13).
Did the NEOG's actual financial results beat the analysts' financial forecasts?
Based on Neogen's last annual report (May 2023), the company's revenue was $822.45M, beating the average analysts forecast of $806.62M by 1.96%. Apple's EBITDA was $37.52M, missing the average prediction of $113.12M by -66.84%. The company's net income was $-22.87M, missing the average estimation of $12.07M by -289.44%. Apple's SG&A was $342.4M, beating the average forecast of $263.38M by 30.00%. Lastly, the company's EPS was $0, missing the average prediction of $1.19 by -100.00%. In terms of the last quarterly report (Aug 2023), Neogen's revenue was $228.99M, missing the average analysts' forecast of $231.1M by -0.92%. The company's EBITDA was $19.14M, missing the average prediction of $31.96M by -40.14%. Neogen's net income was $1.5M, missing the average estimation of $5.42M by -72.25%. The company's SG&A was $90.9M, beating the average forecast of $76.95M by 18.13%. Lastly, the company's EPS was $0, missing the average prediction of $0.025 by -100.00%